• Corpus ID: 207859160

CONTINUOUS INFUSION OF OXYTOCIN FOR CESAREAN

@inproceedings{Sumikura2016CONTINUOUSIO,
  title={CONTINUOUS INFUSION OF OXYTOCIN FOR CESAREAN},
  author={Hiroyuki Sumikura and Eiichi Inada},
  year={2016}
}
Recent findings Rational use of uterotonics for cesarean section has been well studied in the past decades. Oxytocin remained as a first line uterotonics for cesarean section. For continuous infusion, it is reported that ED90 is higher for laboring parturients than for nonlaboring parturients (6.2 vs. 44.2 IU/h) implying that protocol for oxytocin infusion should be different between laboring patients with prior exposure to oxytocin and nonlaboring patients. For bolus administration, ‘rule of… 
No Paper Link Available

References

SHOWING 1-10 OF 46 REFERENCES
Impact of a third stage of labor oxytocin protocol on cesarean delivery outcomes.
Oxytocin Requirements at Elective Cesarean Delivery: A Dose-Finding Study
TLDR
The bolus dose of oxytocin used at elective cesarean deliveries in nonlaboring women can be significantly reduced while maintaining effective uterine contraction, but may require modification of the techniques to remove the placenta.
Minimum effective bolus dose of oxytocin during elective Caesarean delivery.
TLDR
It is shared by the authors' concern that bolus dosing of 5 units oxytocin may produce potentially serious cardiovascular side-effects but suggest that slowing the rate of delivery rather than reducing the dose may be more appropriate.
The ED90 of Prophylactic Oxytocin Infusion After Delivery of the Placenta During Cesarean Delivery in Laboring Compared with Nonlaboring Women: An Up-Down Sequential Allocation Dose-Response Study
TLDR
Test the hypothesis that parturients who receive intrapartum exogenous oxytocin therapy, and who subsequently undergo cesarean delivery for labor dystocia, will have a higher estimated effective dose in 90% of paturients (ED90) for Oxytocin infusion in the third stage of labor compared with nonlaboring parturient.
Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist
TLDR
Recent research elucidates the therapeutic range of oxytocin during caesarean delivery, as well as receptor desensitization, and recommends evidenced-based protocols for the prevention and treatment of uterine atony during caeasean delivery.
Minimum Oxytocin Dose Requirement After Cesarean Delivery for Labor Arrest
TLDR
This dose is 9 times more than previously reported after elective cesarean delivery in nonlaboring women at term, suggesting oxytocin receptor desensitization from exogenous Oxytocin administration during labor.
Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2
TLDR
In women at low risk for PPH undergoing elective Cesarean delivery under spinal anesthesia, carbetocin is similarly effective in doses of 20-100 μg, and there is a high incidence of hypotension associated with carbetokin in these doses.
Carbetocin at Cesarean delivery for labour arrest: a sequential allocation trial to determine the effective dose
TLDR
This dose of carbetocin is higher than the currently recommended dose of 100 µg at elective CD and should not be used routinely given the uncertainty regarding its efficacy and the high incidence of arrhythmias at higher doses.
Acute Tocolysis for Uterine Activity Reduction in Term Labor: A Review
TLDR
This review critically evaluates the efficacy of different tocolytics in reducing uterine pressure and contractions in term labor and concludes that the oxytocin receptor antagonist atosiban has a high specificity for the uterus with limited or no systemic effects and could therefore be an attractive alternative for use interm labor.
Second-line uterotonics and the risk of hemorrhage-related morbidity.
...
1
2
3
4
5
...